What is Ultragenyx Pharmaceutical's revenue?

Ultragenyx Pharmaceutical (RARE) reported revenue of $136M in Q1 2026.

How has Ultragenyx Pharmaceutical's revenue changed year-over-year?

Ultragenyx Pharmaceutical's revenue decreased by 2.2% year-over-year, from $139M to $136M.

What is the long-term trend for Ultragenyx Pharmaceutical's revenue?

Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's revenue has grown at a 17.6% compound annual growth rate (CAGR), from $351.41M to $672.71M.

Ultragenyx Pharmaceutical RARE Revenue

Revenue at other companies

HTF

Heartflow, Inc. Common StockHTFL

$52.59M+41.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Minerals TechnologiesMTX

$546.9M+11.2%

Lincoln Educational Services CorporationLINC

$143.96M+22.5%

Other financials

Income statement

See full

Revenue$136.0M-2.2%

Operating income-$169.0M-18.2%

Net income-$185.0M-22.5%

EPS (diluted)-$1.84-17.2%

Balance sheet

See full

Cash & equivalents$175.0M+37.8%

Total debt$36.0M-10.8%

Total equity-$236.0M-264%

Total assets$1.3B-1.2%

Cash flow

See full

Operating cash flow-$197.0M-18.7%

CapEx$1.0M0.0%

Free cash flow-$198.0M-18.6%

Valuation

See full

Market cap$2.87B-39.4%

Profitability

See full

Gross margin97.2%—

Operating margin-83.8%-3.0pp

Net margin-90.9%-2.1pp

FCF margin-75.1%+10.7pp

Returns & leverage

See full

Return on equity-325.6%+36.9pp

Debt / equity3.7×—

Current ratio2×-0.4×

Where this comes from

Reported directly by Ultragenyx Pharmaceutical in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's revenue?: Ultragenyx Pharmaceutical (RARE) reported revenue of $136M in Q1 2026.
How has Ultragenyx Pharmaceutical's revenue changed year-over-year?: Ultragenyx Pharmaceutical's revenue decreased by 2.2% year-over-year, from $139M to $136M.
What is the long-term trend for Ultragenyx Pharmaceutical's revenue?: Over 4 years (2021 to 2025), Ultragenyx Pharmaceutical's revenue has grown at a 17.6% compound annual growth rate (CAGR), from $351.41M to $672.71M.